Medifast Inc
NYSE:MED
Medifast Inc
NYSE:MED
Price:
13.83
USD
-1.28%
Market Closed
Market Cap:
151.3m
USD
Balance Sheet
Balance Sheet Decomposition
Medifast Inc
Medifast Inc
| Current Assets | 214.4m |
| Cash & Short-Term Investments | 162.3m |
| Other Current Assets | 52.1m |
| Non-Current Assets | 69.8m |
| PP&E | 48.7m |
| Other Non-Current Assets | 21.1m |
Balance Sheet
Medifast Inc
Medifast Inc
Currency: USD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
42
|
52
|
75
|
81
|
77
|
164
|
104
|
88
|
94
|
91
|
|
| Cash Equivalents |
42
|
52
|
75
|
81
|
77
|
164
|
104
|
88
|
94
|
91
|
|
| Short-Term Investments |
25
|
24
|
24
|
20
|
16
|
11
|
5
|
0
|
56
|
71
|
|
| Total Receivables |
3
|
3
|
3
|
1
|
7
|
1
|
1
|
0
|
9
|
0
|
|
| Accounts Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
2
|
1
|
2
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
13
|
18
|
19
|
39
|
49
|
53
|
180
|
119
|
55
|
42
|
|
| Other Current Assets |
3
|
4
|
4
|
5
|
6
|
6
|
16
|
16
|
11
|
10
|
|
| Total Current Assets |
87
|
101
|
125
|
146
|
154
|
234
|
307
|
223
|
224
|
214
|
|
| PP&E Net |
29
|
20
|
19
|
20
|
39
|
38
|
81
|
76
|
67
|
49
|
|
| PP&E Gross |
29
|
20
|
19
|
20
|
39
|
38
|
81
|
76
|
67
|
49
|
|
| Accumulated Depreciation |
47
|
36
|
34
|
35
|
23
|
27
|
33
|
40
|
47
|
58
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
4
|
2
|
4
|
11
|
18
|
19
|
21
|
|
| Total Assets |
116
N/A
|
121
+4%
|
146
+20%
|
169
+16%
|
195
+15%
|
276
+42%
|
398
+44%
|
316
-21%
|
310
-2%
|
284
-8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
11
|
10
|
16
|
22
|
23
|
36
|
71
|
59
|
48
|
23
|
|
| Accrued Liabilities |
8
|
11
|
15
|
29
|
39
|
54
|
74
|
55
|
42
|
39
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
4
|
6
|
9
|
18
|
21
|
25
|
27
|
2
|
2
|
|
| Total Current Liabilities |
24
|
24
|
37
|
60
|
79
|
111
|
170
|
141
|
92
|
64
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
10
|
8
|
26
|
20
|
16
|
10
|
|
| Total Liabilities |
28
N/A
|
25
-8%
|
37
+48%
|
60
+62%
|
90
+49%
|
119
+32%
|
196
+65%
|
161
-18%
|
108
-33%
|
74
-32%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
89
|
94
|
104
|
131
|
169
|
154
|
190
|
140
|
175
|
177
|
|
| Additional Paid In Capital |
0
|
3
|
5
|
9
|
0
|
8
|
12
|
22
|
27
|
33
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
31
|
64
|
5
|
0
|
6
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
89
N/A
|
96
+8%
|
109
+13%
|
109
+0%
|
105
-4%
|
157
+50%
|
203
+29%
|
155
-23%
|
201
+30%
|
210
+4%
|
|
| Total Liabilities & Equity |
116
N/A
|
121
+4%
|
146
+20%
|
169
+16%
|
195
+15%
|
276
+42%
|
398
+44%
|
316
-21%
|
310
-2%
|
284
-8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
12
|
12
|
12
|
12
|
11
|
11
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
